Non-transitional Cell Carcinoma of the Urothelial Tract
📧 Sign up to get email alerts when something new happens for Non-transitional Cell Carcinoma of the Urothelial Tract.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract [Phase 2]
Phase 2 trial evaluating durvalumab with tremelimumab for metastatic non-transitional cell carcinoma of the urothelial tract shows completed…